What’s inside
View ResearchExplore the clinical utility of Basophil and B-cell biomarkers in monitoring disease activity for food allergies and oral immunotherapy. This study highlights the significance of CD63 and CD203c expression on basophils and CD73 expression on B cells in patients undergoing peanut oral immunotherapy (OIT). The research demonstrates that these biomarkers can potentially indicate desensitization and long-term immunological tolerance, aiding in better management and monitoring of peanut allergies.
Basophil Biomarkers in Food Allergy Monitoring
Assessing basophil biomarkers' clinical utility for monitoring disease activity in food allergy patients undergoing oral immunotherapy.
B-Cell Biomarkers in Food Allergy Treatment
Evaluating B-cell biomarkers to track immune changes in food allergy and oral immunotherapy patients.
Peanut Allergy and Oral Immunotherapy
Investigating the effects of peanut oral immunotherapy on basophil activation and immune response.
CD63 and CD203c as Indicators of Desensitization
Study shows decreased CD63/CD203c ratio in basophils of patients undergoing peanut oral immunotherapy.
CD73 Expression in Peanut Allergy Patients
Analysis reveals significant changes in CD73 expression on B cells in peanut allergy and immunotherapy patients.
Immune Monitoring During Peanut Immunotherapy
Highlighting the importance of immune monitoring in peanut oral immunotherapy to predict treatment success and manage complications.
.svg)
.jpg)
.webp)
